March 19, 2010 at 6:29 pm | Psoriasis News
- Posted by PsoriasisAdmin |
Jordan eyes bigger pie of Dead Sea cosmetics market
AMMAN (AFP) – Jordan is vying to break Israel’s dominance of a major cosmetics industry based on Dead Sea minerals famous for their therapeutic qualities but, despite an abundance of mud, still has far to go.
Read more on AFP via Yahoo!Xtra News
Tweet This Post
March 17, 2010 at 6:34 pm | Psoriasis News
- Posted by PsoriasisAdmin |
The Farmer File: Bumps, not beaver fever
Way back when, say two or three years ago, which is way back when in our big screen and small screen digital world, we had an informal rule for cocktail parties.It was our 10-minute rule, not original with us, but a good idea no matter who thought it up. The rule was this: Only in the first 10 minutes of guests’ arrivals could they talk about their latest ills, pills or medical bills. We needed …
Read more on Naples Daily News
Tweet This Post
March 15, 2010 at 6:45 pm | Psoriasis News
- Posted by PsoriasisAdmin |
The Nothing Cure: Taking the placebo effect seriously
Instead of ignoring the placebo effect, doctors should try to enhance it, says a Harvard Medical School professor.
Read more on CTV.ca
Tweet This Post
March 13, 2010 at 7:12 pm | Psoriasis News
- Posted by PsoriasisAdmin |
Successful Investing: What health reform means for drug stocks
The complex prescription for successful health-care investing usually includes the careful consideration of drug pipelines, current-product sales, patent expirations, potential mergers and stock dividends. Add to that list in 2010 an untested ingredient called health-care reform. “Institutional investors don’t want to see big headlines about the health-care industry that they weren’t able to …
Read more on Richmond Times-Dispatch
Tweet This Post
March 11, 2010 at 6:46 pm | Psoriasis News
- Posted by PsoriasisAdmin |
University Hospitals startup company opens in Akron
University Hospitals startup company opens in Akron
Read more on Akron Beacon Journal
Tweet This Post
March 9, 2010 at 9:54 pm | Psoriasis News
- Posted by PsoriasisAdmin |
Isotechnika Pharma receives National Research Council IRAP funding for NICAM program
Isotechnika Pharma Inc. today announced that it has received funding approval from the National Research Council’s Industrial Research Assistance Program for its Non-Immunosuppressive Cyclosporin Analog Molecules program.
Read more on CNW Group via Yahoo! Finance
Tweet This Post
March 7, 2010 at 6:15 pm | Psoriasis News
- Posted by PsoriasisAdmin |
European authorities accept voclosporin for regulatory review
Isotechnika Pharma Inc. today announced that the European Medicines Agency has validated the Marketing Authorization Application filed by its partner, Lux Biosciences, Inc., for voclosporin.
Read more on CNW Group via Yahoo! Finance
Tweet This Post
March 5, 2010 at 6:50 pm | Psoriasis News
- Posted by PsoriasisAdmin |
DARA BioSciences Closes at Market Private Placement Transaction
RALEIGH, N.C. — DARA BioSciences, Inc. , a biopharmaceutical development company, today announced that on February 26, 2010 it closed a private placement financing with certain existing accredited individual investors.
Read more on GlobeNewswire via Yahoo! Finance
Tweet This Post
March 3, 2010 at 9:11 pm | Psoriasis News
- Posted by PsoriasisAdmin |
Absorption Systems, a Leader in Drug Safety Testing, Becomes Society of Toxicology Affiliate
EXTON, Pa.—-Absorption Systems, a leader in testing drugs for ADMET , has joined the Society of Toxicology, the premier global professional association of toxicologists, as an SOT Affiliate.
Read more on Business Wire via Yahoo! Finance
Tweet This Post
March 1, 2010 at 6:25 pm | Psoriasis News
- Posted by PsoriasisAdmin |
Merck makes fourth quarter net profit
German drug maker Merck KGaA said it made a net profit in the fourth quarter, compared with a loss a year ago.
Read more on Brisbane Times
Tweet This Post